'Variants matter': Novavax CEO on COVID-19 virus
... And now today, we've put together eight different large-scale commercial production plants, either ones that we bought or ones we're partnering with other companies or what's called contract manufacturing organizations.
So we've got them in India, in Europe, in the US, and in Asia. And so we have now the capacity that I refer to as the beauty of our platform...
... Well, all we have to do with these variants-- they're basically the same entity, and we can make it using the same process. So it's not the months of scale-up learning that we have to do. We can just, instead of making a Wuhan batch, we can make a UK variant batch or a South Africa variant batch. We very quickly could switch it...
... Well, we would not be able to roll out the vaccine before the trial, because the trial will be over. It will be over by March. We will not be able to get a vaccine approved and rolled out before then. So I know what you're saying, but we'll be able to get the data from the trial....
finance.yahoo.com/video/...r-novavax-ceo-covid-215450908.html